# Tempus AI, Inc. (TEM)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $9M  
**Price:** $49.48 (+1.35%)

> Tempus AI, Inc. is a healthcare technology company that applies artificial intelligence and machine learning to clinical and molecular data to support medical decision-making. The company operates a data and analytics platform designed to structure, integrate, and analyze diverse healthcare information, including genomic, imaging, and electronic health record data, with the goal of enabling more precise and personalized care. Tempus AI focuses on multiple therapeutic areas such as oncology, neuropsychiatry, cardiology, infectious disease, and radiology, providing tools that help clinicians interpret complex data and select appropriate diagnostics or treatment options. Its offerings include intelligent diagnostics that use AI, including generative AI, to make laboratory testing more accurate and tailored to individual patients. Headquartered in Chicago, Illinois and founded in 2015, Tempus AI today plays a notable role in the health information services segment, serving healthcare providers, life sciences companies, and research institutions that rely on data-driven insights to improve clinical workflows and patient outcomes.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $1.27B | — | -$253M | -$245M | $-1.41 |
| 2024 | $693M | — | -$691M | -$706M | $-6.23 |
| 2023 | $532M | — | -$196M | -$214M | $-4.20 |
| 2022 | $321M | — | -$265M | -$290M | $-5.30 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $2.27B | $1.78B | $491M | $605M | — |
| 2024 | $926M | $870M | $56M | $341M | — |
| 2023 | $564M | $841M | -$1.38B | $166M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$218M | $21M | -$239M |
| 2024 | -$189M | $22M | -$211M |
| 2023 | -$214M | $35M | -$249M |
| 2022 | -$168M | $18M | -$187M |

Source: [CompaniesByCap](https://companiesbycap.com/company/TEM)